Earnings History Data for NovaBay Pharmaceuticals, Inc. (NBY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-11-2023 AH NBY NovaBay Pharmaceuticals, Inc. 1.45 -0.37 0.00 -3.50 NovaBay GAAP EPS of -$0.37 beats by $0.04, revenue of $3.27M misses by $0.27M
[11/9/2023 4:16 PM]
0.3202 -0.03 
(-8.23%)
0.33 -0.02 
(-5.39%)
0.31 - 3.63 54,222 60,000 2,648
11-05-2023 AH 4:05 PM ET
(May 11)
NBY NovaBay Pharmaceuticals, Inc. 1.99 -0.85 0.00 0.00 NovaBay GAAP EPS of -$0.85 beats by $0.06, revenue of $3.12M misses by $0.08M
[5/11/2023 4:17 PM]
0.9550 -0.04 
(-4.47%)
0.95 -0.05 
(-5.18%)
0.85 - 12.64 1,348,074 90,000 17,310
30-03-2023 AH 4:05 PM ET
(Mar 30)
NBY NovaBay Pharmaceuticals, Inc. 4.13 -4.33 0.00 -0.70 1.65 -0.07 
(-4.04%)
0.0 0.0 
(0.00%)
1.24 - 12.64 12,281 10,000 0
14-11-2022 AH 4:05 PM ET
(Nov 14)
NBY NovaBay Pharmaceuticals, Inc. 5.20 -0.10 0.00 -0.05 NovaBay GAAP EPS of -$0.10, revenue of $3.83M
[11/14/2022 4:13 PM]
0.0853 -3.06 
(-97.29%)
0.10 -3.04 
(-96.82%)
0.08 - 20.65 9,330,649 20,000 686,947
11-08-2022 AH 4:05 PM ET
(Aug 11)
NBY NovaBay Pharmaceuticals, Inc. 12.63 -0.04 0.00 -0.04 NovaBay GAAP EPS of -$0.04 in-line, revenue of $3.04M misses by $0.47M
[8/11/2022 4:14 PM]
0.2798 -0.03 
(-8.29%)
0.30 -0.01 
(-1.67%)
0.17 - 0.77 803,466 1,470,000 11,043
12-05-2022 AH 4:05 PM ET
(May 12)
NBY NovaBay Pharmaceuticals, Inc. 10.29 N/A 0.00 -0.04 NovaBay GAAP EPS of $0.00 beats by $0.03, revenue of $2.63M misses by $0.63M
[5/12/2022 4:17 PM]
0.1943 0.01 
(6.44%)
0.20 0.02 
(12.33%)
0.17 - 0.88 854,010 380,000 996
29-03-2022 AH 4:05 PM ET
(Mar 29)
NBY NovaBay Pharmaceuticals, Inc. 16.19 -0.02 0.00 -0.04 NovaBay GAAP EPS of -$0.02 beats by $0.03, revenue of $2.64M misses by $0.71M
[3/29/2022 4:25 PM]
0.3074 -0.01 
(-3.94%)
0.31 -0.01 
(-3.09%)
0.26 - 1.02 449,030 500,000 25,186
12-08-2021 AH 4:05 PM ET
(Aug 12)
NBY NovaBay Pharmaceuticals, Inc. 26.70 -0.04 0.00 -0.15 NovaBay EPS in-line, beats on revenue
[8/12/2021 4:24 PM]
0.6397 -0.01 
(-1.75%)
0.64 -0.01 
(-1.32%)
0.52 - 1.79 1,585,432 3,320,000 3,460
06-05-2021 AH 4:05 PM ET
(May 6)
NBY NovaBay Pharmaceuticals, Inc. 33.13 -0.04 0.00 -0.06 NovaBay EPS in-line, misses on revenue
[5/6/2021 4:45 PM]
0.7274 -0.02 
(-2.03%)
0.72 -0.02 
(-2.96%)
0.52 - 1.94 634,763 460,000 5,145
25-03-2021 AH 4:05 PM ET
(Mar 25)
NBY NovaBay Pharmaceuticals, Inc. 43.45 -0.04 0.00 -0.13 NovaBay EPS in-line, misses on revenue
[3/25/2021 4:14 PM]
0.9198 -0.06 
(-6.15%)
0.94 -0.04 
(-4.06%)
0.52 - 1.94 1,187,350 3,230,000 54,659
12-11-2020 AH 4:05 PM ET
(Nov 12)
NBY NovaBay Pharmaceuticals, Inc. 24.21 -0.08 0.00 -0.02 NovaBay EPS misses by $0.04, misses on revenue
[11/12/2020 4:10 PM]
0.6106 -0.04 
(-6.05%)
0.5489 -0.10 
(-15.54%)
0.24 - 1.94 1,512,577 908,308 130,679
06-08-2020 AH 4:05 PM ET
(Aug 6)
NBY NovaBay Pharmaceuticals, Inc. 44.06 -0.15 0.00 -0.14 NovaBay EPS misses by $0.09, beats on revenue
[8/6/2020 4:25 PM]
1.15 -0.18 
(-13.68%)
1.12 -0.21 
(-15.79%)
0.24 - 1.94 2,458,650 2,915,289 448,938